Fairhaven Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.56M |
| 2 |
Archer Daniels Midland
ADM
|
+$1.46M |
| 3 |
Target
TGT
|
+$1.38M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.38M |
| 5 |
Enbridge
ENB
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.6M |
| 2 |
Walt Disney
DIS
|
+$1.49M |
| 3 |
Novartis
NVS
|
+$1.33M |
| 4 |
Roblox
RBLX
|
+$1.07M |
| 5 |
Unilever
UL
|
+$359K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.86% |
| 2 | Healthcare | 7.71% |
| 3 | Consumer Discretionary | 7.68% |
| 4 | Financials | 7.14% |
| 5 | Communication Services | 3.21% |
Similar funds
Fairhaven Wealth Management's Q1 2022 Portfolio in Review
As of Q1 2022, Fairhaven Wealth Management held 136 positions worth $246M, down 3.9% from $256M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Fairhaven Wealth Management deployed $8.11M of net new capital in Q1 2022, opening 15 new positions and adding to 60 existing holdings. Its largest new stake was Merck: 19,753 shares worth $1.62M.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $1.6M trimmed.
- Fairhaven Wealth Management's largest Q1 2022 buy was Merck: 19,753 shares worth $1.62M.
- Fairhaven Wealth Management added most to iShares Core S&P 500 ETF in Q1 2022, an estimated $1.38M increase.
- Fairhaven Wealth Management's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.6M.
- Fairhaven Wealth Management fully exited Unilever in Q1 2022, selling an estimated $359K.
- Fairhaven Wealth Management's ten largest holdings make up 58% of its $246M portfolio in Q1 2022.
- Fairhaven Wealth Management opened 15 new positions and closed 8 in Q1 2022.
- Fairhaven Wealth Management's portfolio value fell 3.9% quarter-over-quarter to $246M.
Based on Fairhaven Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.